Keyphrases
Tanzania
100%
Mwanza
83%
Tuberculosis Patients
43%
Pulmonary Tuberculosis
43%
Mycobacterium Tuberculosis (M. tb)
37%
Tuberculosis
36%
Diabetes
33%
Acute Phase Reactants
29%
Tuberculosis Treatment
22%
Glycoprotein
21%
Interferon-gamma Release Assay
19%
Co-infected Patients
19%
Predictors of Physical Activity
16%
Latent Infection
16%
Interferon-α (IFN-α)
16%
Thermal Stability
16%
Urban Adults
16%
Release Assay
16%
Risk Factors
16%
Grip Strength
16%
Prospective Cohort Study
16%
Heart Rate Response
16%
Physical Activity Level
16%
Genotype
16%
Randomized Controlled Trial
16%
Accelerometry
16%
Strong Predictor
16%
Protein Supplementation
16%
Mortality Prediction
16%
Confidence Interval
16%
Latent Mycobacterium Tuberculosis Infection
16%
Body Composition
16%
Household Contacts
16%
α1-acid Glycoprotein
13%
Sputum Smear Negative
11%
Cluster of Differentiation 4
11%
HIV Infection
11%
Sputum
11%
HIV Patients
10%
Incubation
8%
Apparently Healthy
8%
Neutrophil Count
8%
Quantiferon TB Gold
8%
Tuberculosis Control
7%
Nontuberculosis
7%
Acute Phase Response
7%
Low-income Countries
6%
Thermic
5%
Spoligotyping
5%
Tuberculosis Activity
5%
Medicine and Dentistry
Interferon
33%
Release Assay
33%
Mycobacterium Tuberculosis
20%
Tuberculosis
20%
Infection
20%
Human Immunodeficiency Virus
19%
Accelerometry
16%
Household
16%
Interferon Gamma Release Assay
16%
Cross Sectional Study
16%
Physical Activity
16%
Prevalence
16%
Tuberculosis Treatment
16%
Prospective Cohort Study
16%
Diabetes
16%
Sputum
13%
Incubation
11%
Orosomucoid
10%
Glycoprotein
10%
Human Immunodeficiency Virus Infection
6%
Linear Regression Analysis
6%
Anemia
6%
Acute Phase Protein
5%
